Therapy selection for Hodgkin lymphoma in sickle cell disease: balancing risks and benefits

•Multiple treatment approaches exist for HL, with similar and excellent efficacy.•Oncologists should consider a patient’s comorbid conditions and related complications when selecting a treatment regimen to minimize the acute and late effects of therapy.